Priced for a smaller company: management is quietly telling investors the business has already outgrown what the numbers
The model's full reasoning — Q3 2019 call → NOWe need to determine if management conveys that outsiders are currently underweighting something the company has already done, and points to a concrete, already-in-place thing whose contribution is still ahead. Let's analyze the transcript. Key points: Management discusses strong Q3 results, ARR growth, ARPS growth, subscriptions, etc. They also announce acquisition of PlanGrid. They talk about construction opportunity, BIM 360, etc. Does management raise a recognition gap? They mention that they are making progress, but do they say that outsiders are underweighting something? They talk about the sum of revenue growth and free cash flow margin crossing 30% and plan to nearly double that. They talk about the transition. But is there a specific claim that the market is not appreciating something already done? They mention that they have hit milestones, but they don't explicitly say "investors are underweighting" or "the market is not modeling correctly." However, they do talk about the transition and how metrics like subscriptions and ARPS are reported, and they say that after this quarter they will stop reporting subs and ARPS quarterly, implying that those metrics are no longer the focus. That could be a recognition gap: outsiders are still focused on subs and ARPS, but the company is moving beyond that. But is that a recognition gap? They say "we will use events like our annual Investor Day to report on important metrics that will help you build your long term models." That suggests they think the current metrics are not the right ones. But is that a claim that outsiders are underweighting something already done? Possibly. But the question asks: "Does management convey that OUTSIDERS ARE CURRENTLY UNDERWEIGHTING SOMETHING THE COMPANY HAS ALREADY DONE?" So we need to see if they point to a concrete, already-in-place thing whose contribution is still ahead. They talk about PlanGrid acquisition. That is a concrete thing they have done (announced acquisition, not yet closed). But they say it will contribute to revenue growth and be modestly negative for profitability and cash flow for the quarter. For fiscal 2020, they expect it to contribute ~100 million in ARR. So that is a concrete thing, but it's not yet closed (expected to close in Q4).
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| KEY | KeyCorp | Q3 2022 | 2022-10-20 | B+ |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
PRPH · Q1 2023 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES The transcript shows management explicitly framing the current market view as mismatched with the company's actual position: "Anybody that's focused on us for earnings, you invested or are following the wrong company," "we're not an earnings story this year," and "focus less on revenues and earnings. This is a transition year." They repeatedly contrast this with the multi-billion-dollar assets already built and operating, whose contributions are still ramping or largely ahead. Concrete already-real items with meaningful payoff still ahead include: - The manufacturing facility (already at capacity, running nearly 100% YoY growth, with $25M revenue target for 2024 constrained only by capacity expansion this year; estimated $70M valuation next year plus $40M working capital and tens of millions in equipment). - Nebula Genomics (already generating >100% YoY revenue growth via direct-to-consumer sales; in-house whole-genome processing and B2B ramp expected in H2 202 3, particularly Q4, after validations complete in a couple of months).
KEY · Q3 2022 → YESThe question is: Does management convey that OUTSIDERS ARE CURRENTLY UNDERWEIGHTING SOMETHING THE COMPANY HAS ALREADY DONE — and does management answer that gap by pointing to at least one CONCRETE, A...YES Management repeatedly frames its interest-rate-risk positioning as something that “sets Key apart” and creates “unique and significant upside” that is not yet reflected in the market’s view of the company. Chris Gorman states that the $1.2 billion annualized benefit from re-pricing existing short-term Treasuries and swaps “ even in the event that rates remain at current levels” will arrive over the next two years, and Don Kimble confirms the same mechanics and timing. The $9 billion in short-term Treasuries and $26 billion in swaps are already on the balance sheet; the contribution is simply not yet in the reported results.
KIM · Q2 2018 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES Management explicitly frames the public-private pricing disconnect as a gap in how the company is valued versus its actual assets and execution. They point to the already-completed Toys "R" Us liquidation process (22 boxes resolved into OpCo and PropCo leases, with seven OpCo leases already signed and seven PropCo under 18-24 month resolution) as a concrete, already-real item whose rent contribution is still largely ahead in the reported results, with the 70-80 bps impact on occupancy and same-site NOI expected to be recaptured in Q3 and beyond.